Prelude Therapeutics (PRLD) Shareholder's Equity Growth (3y) (2022 - 2026)
Prelude Therapeutics (PRLD) Shareholder's Equity Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Prelude Therapeutics |
314.40 Mn |
169.80 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-29.98% |
| Dec 31, 2025 |
-29.45% |
| Sep 30, 2025 |
-35.43% |
| Jun 30, 2025 |
-31.97% |
| Mar 31, 2025 |
-26.68% |
| Dec 31, 2024 |
-22.82% |
| Sep 30, 2024 |
-20.49% |
| Jun 30, 2024 |
-18.31% |
| Mar 31, 2024 |
-16.08% |
| Dec 31, 2023 |
3.77% |
| Sep 30, 2023 |
1.43% |
| Jun 30, 2023 |
79.47% |
| Mar 31, 2023 |
70.92% |
| Dec 31, 2022 |
81.26% |
| Sep 30, 2022 |
95.54% |
